Stay updated on Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision: v3.4.3 is shown, replacing the previous v3.4.2. No study data or actionable details are altered.
    Difference
    0.1%
    Check dated 2026-03-11T18:21:25.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government-funding downtime notice and the previous Revision: v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-11T09:53:09.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice regarding potential updates due to funding and a new revision stamp (Revision: v3.4.1) were added, replacing the previous v3.4.0. These changes do not affect study data, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T06:29:31.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a glossary and shows new versioning details: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The older labels Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.3%
    Check dated 2026-01-28T04:33:23.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision text updated from v3.3.3 to v3.3.4 in the page header.
    Difference
    0.1%
    Check dated 2026-01-14T01:00:53.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The Locations section now lists Beijing Municipality as a separate location, replacing the previous combined Beijing Municipality Locations. Page revision updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed.
    Difference
    0.3%
    Check dated 2025-12-23T09:15:04.000Z thumbnail image

Stay in the know with updates to Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib vs Fruquintinib in Colorectal Cancer Clinical Trial page.